OpenURL Connection Search

Select item for more details and to access through your institution.

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 6, p. 840, doi. 10.1038/bmt.2010.199
By:
- Tack, G. J.;
- Wondergem, M. J.;
- Al-Toma, A.;
- Verbeek, W. H. M.;
- Schmittel, A.;
- Machado, M. V.;
- Perri, F.;
- Ossenkoppele, G. J.;
- Huijgens, P. C.;
- Schreurs, M. W. J.;
- Mulder, C. J. J.;
- Visser, O. J.
Publication type:
Article
Disappointing outcome of allogeneic hematopoietic SCT in two EATL patients.
Published in:
2010
By:
- Regelink, J. C.;
- Tack, G. J.;
- Huijgens, P. C.;
- Mulder, C. J..J.;
- Janssen, J. J. W. M.;
- Visser, O.
Publication type:
Letter
Serum I- FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 4, p. 482, doi. 10.1111/apt.12194
By:
- Adriaanse, M. P. M.;
- Tack, G. J.;
- Passos, V. Lima;
- Damoiseaux, J. G. M. C.;
- Schreurs, M. W. J.;
- Wijck, K.;
- Riedl, R. G.;
- Masclee, A. A. M.;
- Buurman, W. A.;
- Mulder, C. J. J.;
- VreugdENhil, A. C. E.
Publication type:
Article
Commentary: tioguanine in the treatment of refractory coeliac disease - authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 6, p. 595, doi. 10.1111/j.1365-2036.2012.05228.x
By:
- Asseldonk, D. P.;
- Tack, G. J.;
- Wanrooij, R. L. J.;
- Bodegraven, A. A.;
- Mulder, C. J.
Publication type:
Article
Tioguanine in the treatment of refractory coeliac disease - a single centre experience.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 3, p. 274, doi. 10.1111/j.1365-2036.2012.05154.x
By:
- Tack, G. J.;
- Asseldonk, D. P.;
- Wanrooij, R. L. J.;
- Bodegraven, A. A.;
- Mulder, C. J.
Publication type:
Article

Found: 5

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy.

Disappointing outcome of allogeneic hematopoietic SCT in two EATL patients.

Serum I- FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.

Commentary: tioguanine in the treatment of refractory coeliac disease - authors' reply.

Tioguanine in the treatment of refractory coeliac disease - a single centre experience.